BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7515442)

  • 1. 14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding properties.
    Archer S; Seyed-Mozaffari A; Jiang Q; Bidlack JM
    J Med Chem; 1994 May; 37(11):1578-85. PubMed ID: 7515442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine.
    Bidlack JM; Kaplan RA; Subbramanian RA; Seyed-Mozaffari A; Archer S
    Biochemistry; 1993 Jul; 32(26):6703-11. PubMed ID: 7687147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists.
    McLaughlin JP; Sebastian A; Archer S; Bidlack JM
    Eur J Pharmacol; 1997 Feb; 320(2-3):121-9. PubMed ID: 9059844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
    Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1107-13. PubMed ID: 7511163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.
    Bidlack JM; Frey DK; Kaplan RA; Seyed-Mozaffari A; Archer S
    Mol Pharmacol; 1990 Jan; 37(1):50-9. PubMed ID: 1688995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).
    Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
    Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
    Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible affinity labeling of opioid receptors via disulfide bonding: discriminative labeling of mu and delta subtypes by chemically activated thiol-containing enkephalin analogs.
    Yasunaga T; Motoyama S; Nose T; Kodama H; Kondo M; Shimohigashi Y
    J Biochem; 1996 Aug; 120(2):459-65. PubMed ID: 8889834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II.
    Búzás B; Tóth G; Cavagnero S; Hruby VJ; Borsodi A
    Life Sci; 1992; 50(14):PL75-8. PubMed ID: 1313131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of opioid receptors in cultured neurons.
    Vaysse PJ; Zukin RS; Fields KL; Kessler JA
    J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity.
    Sebastian A; Bidlack JM; Jiang Q; Deecher D; Teitler M; Glick SD; Archer S
    J Med Chem; 1993 Oct; 36(21):3154-60. PubMed ID: 7693944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and pharmacological characterization of a rat kappa opioid receptor.
    Meng F; Xie GX; Thompson RC; Mansour A; Goldstein A; Watson SJ; Akil H
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9954-8. PubMed ID: 8234341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
    Newman LC; Sands SS; Wallace DR; Stevens CW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothesis that antagonism of fentanyl analgesia by 2-chloroprocaine is mediated by direct action on opioid receptors.
    Coda B; Bausch S; Haas M; Chavkin C
    Reg Anesth; 1997; 22(1):43-52. PubMed ID: 9010946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.